IAS 2025, the 13th IAS Conference on HIV Science, will take place in Kigali, Rwanda, and virtually, from 13 to 17 July 2025.
The IAS Conference on HIV Science is the world’s most influential meeting on HIV research and its applications. This biennial conference presents the critical advances in basic, clinical and operational HIV research that move science into policy and practice. Through its open and inclusive programme, the meeting sets the gold standard of HIV science, featuring highly diverse and cutting-edge research. IAS 2025 will also address the current political and financial issues affecting the HIV response, including the implications for Africa and around the world.
Roche is proud to partner with key stakeholders such as The Global Fund and PEPFAR, to meet the UNAIDS HIV 95:95:95 goals stating that by 2030, 95% of all people living with HIV will know their HIV status, 95% of all people with diagnosed HIV infection will receive sustained antiretroviral therapy, and 95% of all people receiving antiretroviral therapy will have durable viral suppression. Our portfolio of products will help meet the first and the third 95.
Roche continues to focus on solutions to make testing available to everyone, regardless of location. To enable greater access to HIV-1 viral load testing, an innovative device was developed to allow for reliable plasma viral load testing, without the need for phlebotomy, centrifugation, or refrigerated sample transportation.1
We look forward to welcoming you to the Roche booth and activities at IAS 2025 including Roche-sponsored symposium, in-booth talks and much more. Please sign up to receive additional details as they are available, or check back here.
